Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-06-10 06:04:27 ET · period of report 2026-06-08 · accession 0002014866-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-10 06:04 | 2026-06-08 | INDV | Preblick Ryan | CFO | S - Sale | $37.70 | -36.0K | 284.8K | -11% | -$1.36M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-08 | S | D | 36,000 | $37.70 | 284,751 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |